Disease management program for asthma: Baseline assessment of resource use

American Journal of Health-System Pharmacy

Volumn 53, Issue 5, 1996, Pages 535-541

  MacKinnon, Neil J ^a,b,e   Flagstad, Michael S ^c   Peterson, Connie R ^d   Mesch Beatty, Karen ^b  

^a UNIVERSITY OF FLORIDA   (United States)

^b University of Wisconsin Health   (United States)

^c Diversified Pharmaceutical Services   (United States)

^d Ambulatory Pharmacy Services   (United States)

^e UNIVERSITY OF FLORIDA HEALTH   (United States)

Author keywords

Anti inflammatory agents; Asthma; Costs; Dosage; Economics; Health care; Health maintenance organizations; Hospitals; Pediatrics; Protocols; Rational therapy; Steroids, cortico ; Sympathomimetic agents

Indexed keywords

ANTIINFLAMMATORY AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID;

ADOLESCENT; ADULT; ARTICLE; ASTHMA; CHILD; DRUG USE; FEMALE; HEALTH MAINTENANCE ORGANIZATION; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RESOURCE MANAGEMENT; TREATMENT PLANNING;

EID: 0029915348     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/53.5.535     Document Type: Article

References (41)

1. Horn SD. Clinical practice improvement: identifying optimal care practices using disease-specific adjustment information. Paper presented at ASHP Midyear Clinical Meeting. Miami Beach, FL; 1994 Dec 4.
2. Al-Assaf AF. Outcome management and TQ. In: Al-Assaf AF, Schmele JA, eds. The textbook of total quality in healthcare. 1st ed. Delray Beach, FL: St. Lucie Press; 1993:221-38.
3. McLaughlin CP, Kaluzny AD. Defining total quality management/continuous quality improvement. In: McLaughlin CP, Kaluzny AD, eds. Continuous quality improvement in health care. 1st ed. Gaithersburg, MD: Aspen Publishers; 1994:3-10.
4. Hathaway MJ. Managing care by managing diseases. Manag Healthc. 1994; 4(Oct):S27-S30.
5. Muirhead G. Is it here? Disease management: a reality check. Drug Top. 1995; 139(Apr 10): 28-33.
6. Shane R. Development and implementation of practice guidelines Part 1. Hasp Formal. 1994; 29:711-9.
7. Puckett W, Egle L, Galt M. Pharmacist empowerment: taking practice guidelines to the next level. Part 2. Hasp Formal. 1994; 29:767-72.
8. Bergman R. Getting the goods on guidelines. Hasp Health Netw. 1994; 68(20):70-4.
9. Parmley WW. Clinical practice guidelines: does the cookbook have enough recipes? JAMA. 1994; 272:1374-5.
10. Ellrodt AG, Conner L, Riedinger M et al. Measuring and improving physician compliance with clinical practice guidelines: a controlled interventional trial. Ann Intern Med. 1995; 122:277-82.
11. Sloan NE, Peroutka JA, Morgan DE et al. Influencing prescribing practices and associated outcomes utilizing the drug use evaluation process. Top Hosp Pharm Manage. 1994; 14(3):1-12.
12. Lomas J, Anderson GM, Domnick-Pierre K et al. Do practice guidelines guide practice? The effect of a consensus statement on the practice of physicians. N Engl J Med. 1989; 321:1306-11.
13. Wilson AL. Influencing prescribers. Top Hosp Pharm Manage. 1994; 14(3):40-6.
14. Shulkin DJ. Enhancing the role of physicians in the cost-effective use of pharmaceutical. Hosp Formul. 1994; 29:262-73.
15. Kanouse DE, Jacoby I. When does information change practitioners' behavior? Int J of Technol Assess Health Care. 1988; 4:27-33.
16. Raisch DW. A model of methods for influencing prescribing: Part I. A review of prescribing models, persuasion theories, and administrative and educational methods. DICP Ann Pharmacother. 1990; 24:417-21.
17. Raisch DW. A model of methods for influencing prescribing: Part II. A review of educational methods, theories of human influence, and delineation of the model. DICP Ann Pharmacother. 1990; 24:537-42.
18. Enright SM. Practice guidelines: tools for clinical practice improvement. Pharmaguide Hosp Med. 1994; 7(6):5-8.
19. Greco PJ, Eisenberg JM. Changing physicians' practices. N Engl J Med. 1993; 329:1271-3.
20. Harms L. Preventable hospitalizations among children in Wisconsin for 1993. Health Data Rev. 1994; 8(10): 1-9.
21. Bone RC. The bottom line in asthma management is patient education. Am J Med. 1993; 94:561-3.
22. Clark NM, Feldman CH, Evans D et al. The impact of health education on frequency and cost of health care use by low income children with asthma. J Allergy Clin Immunol. 1986; 78:108-15.
23. Mayo PH, Richman J, Harris HW. Results of a program to reduce admissions for adult asthma. Ann Intern Med. 1990; 112:864-71.
24. Weiss KB, Gergen PJ, Hodgson TA. An economic evaluation of asthma in the United States. N Engl J Med. 1992; 326:862-6.
25. Gergen PJ, Mullally DI, Evans R III. National survey of prevalence of asthma among children in the United States, 1976 to 1980. Pediatrics. 1988; 81.1-7.
26. Gergen PJ, Weiss KB. Changing patterns of asthma hospitalization among children: 1979 to 1987. JAMA. 1990; 264:1688-92.
27. Weiss KB, Wagener DK. Changing patterns of asthma mortality: identifying target populations at high risk. JAMA. 1990; 264:1683-7.
28. Sheffer AL, chairman. Guidelines for the diagnosis and management of asthma: National Heart, Lung, and Blood Institute National Asthma Education Program expert panel report. J Allergy Clin Immunol. 1991; 88(3, suppl):425-534.
29. International consensus report on diagnosis and treatment of asthma, United States. Washington, DC: U.S. Department of Health and Human Services, 1992; publication no. 92-3091.
30. Kolb KW. Pharmacotherapy quality improvement in the managed care setting. Top Hasp Pharm Manage. 1995; 14(4):8-19.
31. Ryan ML, Chaffee BW. Development of a continuous quality improvement/total quality management program for medication use monitoring. Top Hosp Pharm Manage. 1995; 14(4):27-47.
32. Muller RJ, Agre P. Patient education: a multidisciplinary approach to influence patient compliance. Top Hosp Pharm Manage. 1991; 10(4):50-8.
33. Horwitz RI, Horwitz SM. Adherence to treatment and health outcomes. Arch Intern Med. 1993; 153(Aug 23): 1863-8.
34. Bjornson DC, Hiner WO Jr, Potyk RP et al. Effect of pharmacists on health care outcomes in hospitalized patients. Am J Hasp Pharm. 1993; 50:1875-84.
35. Borgsdorf LR, Miano JS, Knapp KK. Pharmacist-managed medication review in a managed care system. Am J Hasp Pharm. 1994; 51:772-7.
36. Mickle TR, Self TH, Farr GE et al. Evaluation of pharmacists' practice in patient education when dispensing a metered-dose inhaler. DICP Ann Pharmacother. 1990; 24:927-30.
37. Kesten S, Zive K, Chapman KR. Pharmacist knowledge and ability to use inhaled medication delivery systems. Chest. 1993; 104:1737-42.
38. Price SO, Newnham MA. Physician perceptions of clinical pharmacy encounters in a family practice clinic. Top Hosp Pharm Manage. 1994; 14(3):13-20.
39. Rosen AB, Peterson ED. Influence of data sources on out-comes research. J Outcomes Manage. 1994; 1(1):9-14.
40. Green J, Wintfeld N. How accurate are hospital discharge data for evaluating effectiveness of care? Med Care. 1993; 31:719-31.
41. Quam L, Ellis LBM, Venus P et al. Using claims data for epidemiologic research. Med Care. 1993; 31:498-507.